Página 3 - Melhores Oncologia Pediátrica oncologistas pediátricos - TOP-68 médicos

Professor Benjamin Dekel is an internationally renowned doctor heading the Pediatric Stem Cell Research Institute and the Division of Pediatric Nephrology at the Sheba Medical Center. He has a Bachelor's degree in Medical Sciences and MD from the Technion, a Doctorate (Ph.D.) from the Weizmann Institute of Science, and has completed multiple residencies, fellowships and post-doctoral fellowships. He has pioneered the identification of stem/progenitor cells for tissue repair and regeneration, and has published over 110 publications in leading medical journals. He is an elected member of the Society of Pediatric Research and the American Society of Clinical Investigation and has won multiple awards.

Head of Department of Pediatric Oncology

Pediatric oncologist

Head of Pediatric oncology Department

Dr. H. Murat Mutus is a pediatric surgeon with expertise in neonatal, thoracic, abdominal, head and neck, urological, gynecological, and oncological surgeries in children. He is known for treating complex congenital anomalies and pediatric tumors. He also performs minimally invasive procedures.

Dr. Mutus has published widely in international medical journals and has presented at many global conferences. He graduated from Marmara University and İnönü University Schools of Medicine. He is dedicated to advancing pediatric surgery through research, high surgical success rates, and personalized patient care.

Dr. Mehmet Ozek is a leading pediatric neurosurgeon with more than 35 years of experience. He focuses on brain and spinal surgery for children. He is well known for treating complex cranial and spinal malformations, brain tumors, and epilepsy in young patients.

Dr. Ozek has performed over 10,000 pediatric neurosurgical procedures. His work has achieved high success rates recognized worldwide. He has published more than 100 articles in peer-reviewed journals and written several book chapters. His research has helped advance pediatric neurosurgery on a global scale.

He is an active member of the International Society for Pediatric Neurosurgery. Dr. Ozek has received several international awards for his work. He holds leadership roles in global pediatric neurosurgical groups and regularly attends international scientific meetings.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

O Dr. Betül Tavıl é professor de hematologia pediátrica e oncologia, especialista de renome mundial em transplante de medula óssea em crianças.

Por que os pacientes confiam no Dr. Tavıl:

• Médico com resultados excepcionais — tratou com sucesso mais de 500 crianças com leucemia e realizou transplante de medula óssea em mais de 100 crianças.
• Especialista em doenças sanguíneas raríssimas em crianças: porfiria eritropoiética congênita, imunodeficiências, doenças sanguíneas genéticas.
• Cientista premiado — recebeu o prémio da Sociedade Turca de Hematologia por conquistas notáveis no tratamento do câncer sanguíneo pediátrico.
• Mais de 150 publicações em revistas internacionais com 1.700+ citações — desenvolve continuamente novos métodos de tratamento.
• Mestre em transplantes de medula óssea complexos em doenças malignas e não malignas em crianças.
• 28 anos de experiência em centros de liderança — Universidade de Hacettepe, Ankara Children's Hospital, Memorial Şişli.
• Realiza consultas online — possibilidade de obter uma opinião especializada de um eminente hematologista pediátrico sem sair de casa.

Education :

Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010

Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011 

Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016

Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012 

Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018

Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021

Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021

Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – present

Educational Qualifications :

1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination  passed on April 2017

2. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 2017

3. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 2018

4. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.

5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.

6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.

7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.

Presentations & Posters :

1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey. 

2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey

3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Interferon Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France

4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.

5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.

6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with systemic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.

7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey

8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey

9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey

10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey

11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey

12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey

13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey

14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey

15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey

16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey

17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France

18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey

19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey

20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey

21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey

22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey

23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey

24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey.

Work Experience :

1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)

2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)

3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)

4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)

5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir)

Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present

2002 – 2008 – Siriraj Medical School, Mahidol University

2008 – 2013 – Department of Internal Medicine, Rajavithi Hospital

2013 – 2015 – Department of Cardiology, Internal Medicine Rajavithi Hospital

2019 – 2020 – Cardiology Intervention, Department of Cardiology, Internal Medicine Rajavithi Hospital

Languages: English and Thai

Pediatric Hematology and Oncology

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Formação

• Faculdade de Medicina de Ege 1978
• Especialização em Pediatria 1982
• Subespecialidade em Oncologia Pediátrica 2002 (Faculdade de Medicina EU)
• Hematologia e Oncologia Pediátrica 2012 (Faculdade de Medicina EU)
• Chefe Adjunto de Clínica 1988 Tepecik EAH
• Chefe de Clínica 1993 Tepecik EAH
• Professor Associado 1995
• Professoria 2002
• Faculdade de Medicina da Universidade de Ege, membro do corpo docente 1998 – 2022
• Departamento de Pediatria da Faculdade de Medicina da UE 2009-2018
• Membro do Conselho de Planejamento e Coordenação de Educação Tepecik (1993-1998)
• Presidente do Comitê de Ética do SSI Hospital de Tepecik (1996-1998)
• Sociedade Turca de Hematologia Pediátrica "Co-Presidente do Grupo de Trabalho em Transplante de Medula Óssea" (2002-2006)
• Sociedade Turca de Hematologia Pediátrica "Grupo de Trabalho em Transplante de Medula Óssea" (2006-2008)
• Sociedade Turca de Hematologia Pediátrica - Responsável pelo Sistema de Registro de Dados "Online" de Transplante de Medula Óssea 2007-presente.
• Presidente da Comissão de Medicina Regenerativa e Células-Tronco da Universidade de Ege, 2011-2021

Filiações Institucionais

• Associação Médica Turca Ramo de Izmir e Kocaeli
• Associação Pediátrica Nacional Turca - İzmir
• Grupo Europeu para Transplante de Medula Óssea (EBMT); a Unidade de Transplante de Medula Óssea Pediátrica da Universidade de Ege foi credenciada pelo Grupo Europeu para Transplante de Medula Óssea (EBMT) em junho de 2007.
• Sociedade Turca de Hematologia Pediátrica - Membro do Conselho por dois mandatos (2005-2009)
• Sociedade Turca de Hematologia - Membro do Conselho por dois mandatos (2001/2005)
• Associação de Oncologia Pediátrica da Turquia
• Fundação de Transplante de Medula Óssea (KITVAK) Membro do Conselho de Curadores

Unidades que ele fundou                        

1- Clínica de Oncologia Pediátrica do SSI Hospital de Tepecik (1990) 
2- Unidade de Transplante de Medula Óssea Pediátrica do SSI Hospital de Tepecik (1992) 
3- Unidade de Transplante de Medula Óssea Pediátrica da Faculdade de Medicina da UE (1998) 
4- FUNDADOR do JOURNAL OF PEDIATRIC RESEARCH, 2014; foi feita a aplicação SCI em 2022. 

Unidades de Transplante que ele contribuiu para o estabelecimento de                        

1. Unidade de Transplante de Medula Óssea Pediátrica do İzmir BUÇH EAH (2019) 
2. Unidade de Transplante de Medula Óssea Pediátrica do Ümraniye EAH (2020) 
3. Unidade de Transplante de Medula Óssea Pediátrica do Kanuni Sultan Süleyman EAH (2020) (Transferida para Çam Sakura EAH)

Prémios

• Parâmetros trombóticos em pacientes com transplante de células-tronco de medula óssea, Congresso de Hematologia Pediátrica, Trabzon 2003
• Antígeno CD133 em Células-Tronco: Congresso de Hematologia Pediátrica 2005. Prémio de pesquisa
• O papel dos Receptores Toll-like em pacientes neutropênicos febris, Prémio de melhor poster. Congresso de Hematologia Turca 2008, Çeşme-İzmir
• Atividade nacional de transplante de células-tronco pediátrico- Apresentação oral segundo prémio, Congresso de Transplante de Células-Tronco da Sociedade de Hematologia Turca, 2022, Antalya

Publicações

Kansoy S. "Transplante de Medula Óssea e Células-Tronco Saúde Infantil e Doenças, 1ª edição, Casa de Impressão da Faculdade de Medicina da UE, 1999, Izmir

Kansoy S. Transplante de Medula Óssea na Talassemia Major III. Livro dos Dias de Talassemia do Egeu, 2000, Izmir

Kansoy S. Padrões da Pediatria KIT na Turquia. Leucemias Agudas da Infância, Antalya 2000: 73-5

Kansoy S. Efeitos tardios em crianças. Edição especial do Jornal de Transplante de Medula Óssea Clínicas Turcas. 2003

Kansoy S. Aplicações de Células-Tronco em Transplante de Medula Óssea e Células-Tronco. Livro do Curso de Enfermagem Oncológica Pediátrica, İzmir, 2005

Kansoy S. Sangue do Cordão Umbilical como Fonte de Células-Tronco. Edição Especial de Células-Tronco. Clínicas da Turquia, 2008

Kansoy S. Transplante de Células-Tronco em Linfomas. Livro de Pediatria Geral, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Transplante de Medula Óssea em Crianças. Pediatria, 2014 e 2017

Kansoy S. Rabdomiossarcoma. Pediatria, 2014 e 2017

Kansoy S. Abordagem à criança com câncer de acordo com os achados clínicos. Pediatria, 2014 e 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Doenças Oncológicas. Pediatria (Ed. A. Cura), 641-672, Casa de Impressão da Universidade de Ege, Izmir, 1999.  (1,05 pontos)

Kansoy S, M.Kantar. Exame de Cabeça, Face e Olho. Exame Físico Prosético Pediátrico e Informação de Sintomas (Ed. A.Cura)

Kantar M. Problemas de Emergência Metabólica em Oncologia. Emergências Oncológicas e Cuidados de Apoio na Infância (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, Izmir, 2003. 

Transplantes de Sangue do Cordão Umbilical na Turquia. HEMATOLOGISTA, 2016

Kansoy S. Tumores do Sistema Nervoso Central em Crianças Pediatria, 2014 e 2017

Leucemia Mieloblástica Aguda em Crianças e seu Tratamento. Livro Textbook de Oncologia Pediátrica, Turco de Poplack, 2020

Atividade nacional de transplante de células-tronco pediátrico, 2020

Indicações de transplante de células-tronco na infância, Clínicas da Turquia - Livro Internacional 2020

Além dos estudos e artigos em revistas internacionais publicadas em grande número, ele está envolvido em estudos multicêntricos internacionais em algumas revistas com alto valor de impacto.

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

Dr. Erkancakir is a specialist in pediatric chest diseases. He has experience with acute and chronic respiratory problems, respiratory tract infections, and bronchoscopic procedures. His areas of focus include asthma, sleep-related breathing disorders, cystic fibrosis, and tuberculosis.

He completed his medical degree at Istanbul University. He continued his specialty training at Göztepe Training and Research Hospital and Marmara University. Dr. Erkancakir has worked at leading institutions, such as Bezmialem Vakıf University and Süreyyapaşa Chest Diseases Training and Research Hospital.

He is an active member of several professional organizations, including the Turkish Thoracic Society and the European Respiratory Society. Dr. Erkancakir has received more than 20 national and international awards for his research and presentations, especially in pediatric pulmonology and cystic fibrosis.